Oxidative Stress and Endothelial Dysfunction in Cardiovascular Disease: Mitochondria-Targeted Therapeutics
Keywords: Antioxidant; Mitochondrial dysfunction; N-acetyl cysteine (NAC); NITROGEN SPECIES (RONS); S-Nitrosothiols (SNOs); The Probucol Quantitative Regression Study (PQRST); angiotensin; antifibrinolitic; asymmetric dimethylargin-ine; atherosclerosis; bioavailability; cardiovas-cular diseases (CVD); cardiovascular dysfunction; carotenoids; cell necrosis; cytochrome; dyslipemia; dyslipidemia; electron transport chain (ETC); endothelial dysfunction; endothelium; endothelium, mitochondria; endothelium-dependent vasodilatation; fragmentation; glutathione peroxidases (GPx); hy-percholesterolemic; hydroxyeicosatetraenoic acids (HETEs; hydroxyocta-decaenoic acids (HODEs); hyperglycemia; hyperinsulinemia; insu-lin resistance; lactoferrin; lipid car-diolipin; lipoic acid; membrane depolarisation; metal-binding proteins; metal-lothionein; mitochondria; neurodegenerative diseases; neuroprotective; nitric oxide; nitroglycerine; obesity; oxidative; oxidative stress; proinflammatory; reactive oxygen species; reactive oxygen species (ROS); synaptosomes; tocopherols; transferrin; triphenylphosphonium (TPP); ubiquinol (MitoQ); vasoconstrictor; vitamin C; vitamin E
Document Type: Research Article
Publication date: 2010-11-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.